NCT05666232

Brief Summary

Background: Liver transplantation (LT) is an extensive operation with various factors contributing to the development of acute kidney injury in the perioperative period. Early diagnosis of AKI can improve clinical outcomes in LT recipients. Renal resistive index is measured in renal arteries and high resistive values are associated with more adverse cardiovascular events and renal failure progression. Myocardial performance index reflects overall cardiac function rather than systolic or diastolic function alone. Aim of the study: to investigate whether combined doppler renal resistive index and myocardial performance index could predict early postoperative acute kidney injury in living donor liver transplant recipients. Study design: a prospective observational study that will be conducted at Liver Transplantation Unit at Mansoura University on 105 consecutive living donor liver transplant recipients. Methods: Renal resistive index (assessed by transabdominal ultrasound) and myocardial performance index (assessed by transthoracic echocardiography) will be measured just before operation, on termination of operation and then daily in the intensive care unit for 7 days. Patients will be observed for development of acute kidney injury.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 27, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

December 27, 2022

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

December 18, 2022

Last Update Submit

December 23, 2022

Conditions

Keywords

2-D EchocardiographyTwo-Dimensional Echocardiographyrenal resistive indexmyocardial performance indexdiagnostie test accuracysensitivity and specificity

Outcome Measures

Primary Outcomes (1)

  • early acute kidney injury (AKI)

    international Club of Ascites' revised classification of AKI in cirrhotic patients as a 0.3 mg/kg increase in serum creatinine

    in the early 48 postoperative hours

Secondary Outcomes (6)

  • stage of AKI

    in the early 48 postoperative hours

  • late AKI

    within 7 days

  • length of ICU stay

    3 months after transplant

  • length of hospital stay

    3 months after transplant

  • three-month mortality

    3 months after transplantation

  • +1 more secondary outcomes

Interventions

Transthoracic echocardiography and transabdominal ultrasonography will be performed before induction of anesthesia, after termination of operation and before transmission to ICU and then daily for the early seven postoperative days. RRI = (peak systolic velocity - end diastolic velocity) ∕ peak systolic velocity: Then, we will obtain the mean RRI from the above three measurements. We will consider RRI ≥0.7 as abnormal and define it as subclinical AKI. Myocardial performance index (using tissue doppler) = (isovolumetric contraction time + isovolumetric relaxation time) / ejection time. We will consider MPI ≥0.4 as abnormal and define it as subclinical LV dysfunction.

Also known as: echocardiography, ultrasonography

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients undergoing living donor liver transplantation at gastrointestinal surgery center at Mansoura University - Mansoura, Egypt.

You may qualify if:

  • patients undergoing right-lobe living-donor liver transplantation

You may not qualify if:

  • preoperative renal impairment (GFR \< 60 ml/min/1.73 m2)
  • known renal artery stenosis
  • patient who underwent previous nephrectomy
  • ischemic heart disease (patient who takes anti-ischemic measures as prescribed by a consultant cardiologist)
  • Patient with arrthymia or who develop persistent intraoperative arrythmia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acute Kidney InjuryHypersensitivity

Interventions

EchocardiographyUltrasonography

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Amr Yassen, MD

    Mansoura University Hospital

    STUDY CHAIR

Central Study Contacts

Ahmed Ali El-din, MSc

CONTACT

Moataz M Emara, MD, EDAIC

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2022

First Posted

December 27, 2022

Study Start

January 1, 2023

Primary Completion

January 1, 2024

Study Completion

April 1, 2024

Last Updated

December 27, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will share

The anonymized patient data will be available on reasonable request after approval of the local IRB.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
within 3 months